Liu Yu, He Wei, Ji Yuan, Wang Qingjie, Li Xun
Department of Cardiology, The Affiliated Changzhou, No.2 People's Hospital of Nanjing Medical University, Changzhou, 213003, Jiangsu, China.
Department of Medical Imaging, The Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, China.
BMC Cardiovasc Disord. 2024 Aug 8;24(1):411. doi: 10.1186/s12872-024-04091-8.
To assess the correlation between high-sensitivity C-reactive protein (Hs-CRP) and the prevalence of cardiovascular disease (CVD) among individuals with diabetes.
A total of 1,555 participants from the National Health and Nutrition Examination Survey were enrolled in this cross-sectional study after excluding individuals without diabetes and those who lacked data on Hs-CRP, diabetes and CVD. All participants were divided into four groups based on quartiles of Hs-CRP: Q1 (≤ 1.20 mg/L), Q2 (1.20-2.86 mg/L), Q3 (2.86-6.40 mg/L), and Q4 (> 6.40 mg/L). Logistic regression analysis, subgroup analysis and restricted cubic spline (RCS) analysis were used to evaluate the correlation between Hs-CRP and the prevalence of CVD in individuals with diabetes.
In univariate logistic regression analysis, a higher level of Hs-CRP was associated with a higher prevalence of CVD (P < 0.05). In the multivariate logistic regression analysis adjusting for confounders, the correlation between Hs-CRP and the prevalence of CVD remained significant (Q3 vs. Q1, OR: 1.505, 95% CI: 1.056-2.147, P = 0.024; Q4 vs. Q1, OR: 1.711, 95% CI: 1.171-2.499, P = 0.006; log(Hs-CRP), OR: 1.504, 95% CI: 1.168-1.935, P = 0.002). Further subgroup analysis showed that a higher Hs-CRP was independently associated with a higher prevalence of CVD in the < 60 years, male, non-hypertension and non-hypercholesterolemia subgroups (P < 0.05). Additionally, RCS analysis revealed a linear positive correlation between Hs-CRP and CVD prevalence (P for nonlinearity = 0.244).
A higher level of Hs-CRP was closely related to a higher prevalence of CVD in people with diabetes.
评估高敏C反应蛋白(Hs-CRP)与糖尿病患者心血管疾病(CVD)患病率之间的相关性。
排除无糖尿病个体以及缺乏Hs-CRP、糖尿病和CVD数据的个体后,共有1555名来自国家健康与营养检查调查的参与者被纳入这项横断面研究。所有参与者根据Hs-CRP四分位数分为四组:Q1(≤1.20mg/L)、Q2(1.20 - 2.86mg/L)、Q3(2.86 - 6.40mg/L)和Q4(>6.40mg/L)。采用逻辑回归分析、亚组分析和限制立方样条(RCS)分析来评估Hs-CRP与糖尿病患者CVD患病率之间的相关性。
在单因素逻辑回归分析中,较高水平的Hs-CRP与较高的CVD患病率相关(P<0.05)。在调整混杂因素的多因素逻辑回归分析中,Hs-CRP与CVD患病率之间的相关性仍然显著(Q3与Q1相比,OR:1.505,95%CI:1.056 - 2.147,P = 0.024;Q4与Q1相比,OR:1.711,95%CI:1.171 - 2.499,P = 0.006;log(Hs-CRP),OR:1.504,95%CI:1.168 - 1.935,P = 0.002)。进一步的亚组分析表明,在<60岁、男性、非高血压和非高胆固醇血症亚组中,较高的Hs-CRP与较高的CVD患病率独立相关(P<0.05)。此外,RCS分析显示Hs-CRP与CVD患病率之间存在线性正相关(非线性P = 0.244)。
较高水平的Hs-CRP与糖尿病患者较高的CVD患病率密切相关。